Abstract
Incubation of [3H]-tyrosine methionine5-enkephalin (MET) with human brain preparations (100,000g supernatant; sections of the limbic system, thalamus, basal ganglia, cerebellum, and cortex) results in its rapid and complete degradation; over 95% of the initial labeled tyrosine is recovered as the free aminoacid within 10 min. Results show a considerable range in the peptide initial velocity (Iv) and half-life (t1/2) degradation values obtained from different brain sections of individual brains, either from the same or from different main brain areas. This relatively wide range of values was scattered, failing to identify consistent differences between the various brains areas studied. Differences in brain tissue storage time or repeated sample freezing and thawing failed to alter significantly either of these kinetic parameters of MET metabolism. Peptide degradation rate (optimum pH and temperature of 7.4 and 37°C, respectively) was concentration-dependent inhibited by known aminopeptidase inhibitors (puromycin, bacitracin, and bestatin, and to a lesser extent by thioridazine). However, it was not significantly affected by either N-carboxymethyl phenyl leucine, captopril or thiorphan [dipeptidyl peptidase(s) or peptidyl dipeptidase(s) inhibitors, respectively]. A better understanding of the mechanisms regulating brain MET metabolism may contribute to the rational design of pharmacological strategies based in the modulation of its bioavailability.
Similar content being viewed by others
References
Cox BM (1988) Peripheral actions mediated by opioid receptor. In: Pasternak GW (ed) The opioid receptors. Humana Press, Clifton, NJ, pp 357–424
Kandel ER, Schwartz JH, Jessell TM (2000) Principles of Neural Science, 4th edn. (revised) New York, McGraw-Hill
Wolf ME, Mosnaim AD, Ignacio R, Puente J (1991) Plasma methionine-enkephalin in post-traumatic stress disorder. Biol Psychiatry 29:305–307
Babst R, Bongiorno L, Marini M, Roda G, Spagnoli G, Urbani A (1999) Trauma decreases leucine enkephalin hydrolysis in human plasma. J Pharmacol Exp Ther 288:766–773
Waldenlind E, Bussone G (2006) Biochemistry, circannual and circadian rtythms, endocrinology, and immunology of cluster headaches. In: Olesen J et al (ed) The headaches, 4th edn. Lippincott Williams & Wilkins, PA
Puente J, Mosnaim AD, Wolf M (2006) Stress, Opioid peptides and the immune response. In: Plotnikoff N et al (ed) Stress, cytokines and the immune response. CRC Press, Taylor & Francis Group, NY, pp 125–142
Spano MS, Ellgren M, Wang X, Hurd YL (2007) Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry 61:554–563
Hambrook JM, Morgan BA, Rance MJ, Smith CF (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262:782–783
Jakubovic A (1988) Degradation of met-enkephalin by extracts of various regions of the human brain: effects of antipsychotics and narcotics in vitro. Peptides 3:21–26
Wolf ME, Szanto P, Marks S, Tung NP, Mosnaim AD (1993) Methionine-enkephalin metabolism by human brain preparations. Soc Biol Psychiatry, CA (Abstract)
McDermott JR, Mantle D. Lauffart B, Kidd AM (1985) Purification and characterization of a neuropeptide-degrading aminopeptidase from human brain. J Neurochem 45:752–759
Hui K-S, Lajtha A (1983) Neuropeptidases. In: Lajtha A (ed) Enzymes in the nervous system handbook of neurochemistry, 2nd edn., vol 4. Plenum, New York, NY, pp 1–19
Taylor A, Jason Warner (2002) Aminopeptidases. In: Smith J, Simons C (eds) Proteinase and peptidase inhibition. Taylor & Francis Group, NY
Gerhartz B, Niestroj AJ, Demuth H-U (2002) Enzyme classes and mechanisms. In: Smith J, Simons CP (eds) Proteinase and peptidase inhibition. Taylor & Francis Group, NY
Mosnaim AD, Puente J, Ranade V, Hoang C, Wolf ME (2004) Inhibition of human plasma leucine-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs. Am J Ther 11:459–465
Ranade VR, Wolf ME, Puente J, Valenzuela MA, Mosnaim AD (2006) Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. Am J Ther 13:261–273
Mosnaim AD, Wolf ME, Nguyen TD, Puente J, Freitag F, Diamond S (2000) Degradation kinetics of leucine-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects. Am J Ther 7:185–194
Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME (2003) In vitro human plasma leucine-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure. Pharmacology 67:6–13
Altstein M, Mittman S, Vogel Z (1981) The effect of barbiturates on the degradation of enkephalin by brain enzymes. Life Sci 28:185–191
Traficante LJ, Turnbull B (1982) Neuropeptide degrading enzyme(s) in plasma and brain: effect of in vivo neuroleptic administration. Pharmac Res Commun 14:341–348
Agam G, Everall IP, Belmaker RH (2002) The postmortem brain in psychiatric research. Kluwer Academic Publishers, Boston, MA
Wolf, ME, Tung NP, Lee H, Shen J, Mosnaim AD (1993) Leucine-enkephalin (LEU) metabolism by human brain preparations. FASEB (Abstract)
Venturelli F, Roscetti G, Possenti R, Vita F, Roda GL (1985) Peripheral enkephalin hydrolysis in different animal species: a comparative study. Neurochem Res 10:333–342
Mosnaim AD, Puente J, Wolf ME, Callaghan OH, Bush R, Diamond S (1988) Studies of the in vitro human plasma degradation of methionine-enkephalin. Gen Pharmacol 19:729–733
Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC (1978) High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276:523–526
Clement-Jones V, Loury PJ, Rees LH, Besser JM (1980) Met-enkephalin circulates in human plasma. Nature 283:295–297
Acknowledgements
This research was supported, in part, by The National Headache Foundation, Chicago, IL, and by Asthmatic Children’s Aid, Skokie, IL.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mosnaim, A.D., Nguyen, T.D., Tse, R. et al. In vitro Methionine5-Enkephalin Degradation Kinetics by Human Brain Preparations. Neurochem Res 33, 81–86 (2008). https://doi.org/10.1007/s11064-007-9418-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9418-6